According to Dynavax Technologies 's latest financial reports and stock price the company's current Operating Margin is 11.12%. At the end of 2024 the company had an Operating Margin of 11.13%.
Year | Operating Margin | Change |
---|---|---|
2024 | 11.13% | -691.97% |
2023 | -1.88% | -104.62% |
2022 | 40.72% | 130.85% |
2021 | 17.64% | -110.91% |
2020 | -161.63% | -62.7% |
2019 | -433.29% | -77.65% |
2018 | -1,938.27% | -93.34% |
2017 | -29,099.08% | 2757.79% |
2016 | -1,018.24% | -61.38% |
2015 | -2,636.89% | 220.65% |
2014 | -822.35% | -24.65% |
2013 | -1,091.44% | -9.89% |
2012 | -1,211.24% | 438.71% |
2011 | -224.84% | -6.04% |
2010 | -239.28% | 538.26% |
2009 | -37.49% | -42.35% |
2008 | -65.02% | -87.11% |
2007 | -504.45% | -59.79% |
2006 | -1,254.45% | 717.43% |
2005 | -153.46% | 34.82% |
2004 | -113.83% | -94.71% |
2003 | -2,150.61% | 64.47% |
2002 | -1,307.57% | 57.93% |
2001 | -827.94% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() Agenus
AGEN | -224.49% | -2,118.79% | ๐บ๐ธ USA |
![]() Biogen BIIB | 17.85% | 60.52% | ๐บ๐ธ USA |
![]() Merck MRK | 31.06% | 179.32% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | 23.75% | 113.58% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | 16.07% | 44.51% | ๐ฌ๐ง UK |
![]() GlaxoSmithKline GSK | 13.32% | 19.78% | ๐ฌ๐ง UK |
![]() Pfizer PFE | 12.60% | 13.31% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | -7.76% | -169.78% | ๐ฎ๐ฑ Israel |
![]() Amgen AMGN | 19.48% | 75.18% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.